GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 678 filers reported holding GLAXOSMITHKLINE PLC in Q4 2013. The put-call ratio across all filers is 0.49 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $6,996,000 | -2.5% | 160,713 | -2.5% | 0.36% | +18.6% |
Q1 2022 | $7,179,000 | -1.6% | 164,818 | -0.3% | 0.31% | +4.8% |
Q4 2021 | $7,293,000 | +13.9% | 165,373 | -1.3% | 0.29% | +7.3% |
Q3 2021 | $6,403,000 | -6.0% | 167,572 | -2.0% | 0.27% | -3.2% |
Q2 2021 | $6,812,000 | +5.7% | 171,047 | -5.3% | 0.28% | -3.1% |
Q1 2021 | $6,447,000 | -12.4% | 180,617 | -9.7% | 0.29% | -12.9% |
Q4 2020 | $7,359,000 | -3.0% | 199,968 | -0.8% | 0.33% | -11.9% |
Q3 2020 | $7,590,000 | -15.0% | 201,662 | -7.9% | 0.38% | -22.3% |
Q2 2020 | $8,930,000 | +6.0% | 218,915 | -1.5% | 0.49% | -11.1% |
Q1 2020 | $8,422,000 | -21.0% | 222,286 | -2.1% | 0.55% | +2.2% |
Q4 2019 | $10,667,000 | +8.7% | 227,001 | -1.3% | 0.54% | +3.7% |
Q3 2019 | $9,812,000 | +6.5% | 229,898 | -0.2% | 0.52% | +8.4% |
Q2 2019 | $9,215,000 | -5.2% | 230,261 | -1.0% | 0.48% | -8.4% |
Q1 2019 | $9,721,000 | -45.0% | 232,612 | -49.7% | 0.52% | -30.3% |
Q4 2018 | $17,662,000 | -5.6% | 462,233 | -0.8% | 0.75% | +11.8% |
Q3 2018 | $18,713,000 | -0.3% | 465,833 | +0.1% | 0.67% | -6.3% |
Q2 2018 | $18,760,000 | +2.6% | 465,386 | -0.5% | 0.72% | +2.3% |
Q1 2018 | $18,277,000 | +9.9% | 467,796 | -0.2% | 0.70% | +14.2% |
Q4 2017 | $16,626,000 | -14.4% | 468,741 | -2.0% | 0.61% | -18.1% |
Q3 2017 | $19,412,000 | -6.7% | 478,141 | -0.9% | 0.75% | -8.5% |
Q2 2017 | $20,801,000 | +2.4% | 482,421 | +0.1% | 0.82% | -1.1% |
Q1 2017 | $20,320,000 | +9.4% | 481,976 | -0.1% | 0.82% | +1.7% |
Q4 2016 | $18,575,000 | -6.5% | 482,347 | +4.7% | 0.81% | -11.3% |
Q3 2016 | $19,870,000 | -0.5% | 460,706 | -0.1% | 0.91% | -2.1% |
Q2 2016 | $19,979,000 | +12.9% | 460,979 | +5.6% | 0.93% | +5.5% |
Q1 2016 | $17,693,000 | -1.4% | 436,329 | -1.9% | 0.88% | -0.6% |
Q4 2015 | $17,953,000 | +0.9% | 444,929 | -3.8% | 0.89% | +1.1% |
Q3 2015 | $17,790,000 | -7.9% | 462,669 | -0.2% | 0.88% | +2.0% |
Q2 2015 | $19,313,000 | -9.7% | 463,719 | +0.0% | 0.86% | -8.9% |
Q1 2015 | $21,399,000 | +8.2% | 463,664 | +0.2% | 0.95% | +7.4% |
Q4 2014 | $19,775,000 | -7.4% | 462,679 | -0.4% | 0.88% | -5.3% |
Q3 2014 | $21,345,000 | -13.9% | 464,329 | +0.1% | 0.93% | -11.7% |
Q2 2014 | $24,804,000 | +1.1% | 463,814 | +1.0% | 1.05% | -4.3% |
Q1 2014 | $24,536,000 | -0.0% | 459,221 | -0.1% | 1.10% | +25.4% |
Q4 2013 | $24,542,000 | +6.1% | 459,676 | -0.3% | 0.88% | -3.0% |
Q3 2013 | $23,128,000 | +0.4% | 460,986 | 0.0% | 0.90% | +9.8% |
Q2 2013 | $23,035,000 | – | 460,986 | – | 0.82% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |